IperionX (NASDAQ:IPX) CEO Anastasios Arima Buys 138,720 Shares

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) CEO Anastasios Arima bought 138,720 shares of the firm’s stock in a transaction dated Friday, July 10th. The shares were acquired at an average price of $3.58 per share, for a total transaction of $496,617.60. Following the completion of the transaction, the chief executive officer owned 12,455,502 shares in the company, valued at $44,590,697.16. This represents a 1.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Anastasios Arima also recently made the following trade(s):

  • On Tuesday, April 28th, Anastasios Arima bought 110,000 shares of IperionX stock. The stock was acquired at an average cost of $4.49 per share, for a total transaction of $493,900.00.

IperionX Trading Down 1.4%

NASDAQ:IPX opened at $24.67 on Tuesday. IperionX Limited Sponsored ADR has a 12-month low of $21.66 and a 12-month high of $61.45. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00. The firm has a 50-day moving average price of $34.10 and a 200 day moving average price of $37.43.

Institutional Trading of IperionX

Several hedge funds have recently modified their holdings of IPX. Van ECK Associates Corp raised its stake in shares of IperionX by 61.0% in the fourth quarter. Van ECK Associates Corp now owns 1,337,343 shares of the company’s stock valued at $48,392,000 after acquiring an additional 506,612 shares during the last quarter. Jane Street Group LLC grew its position in IperionX by 62.5% during the 4th quarter. Jane Street Group LLC now owns 129,020 shares of the company’s stock worth $4,669,000 after acquiring an additional 49,645 shares during the last quarter. Millennium Management LLC bought a new stake in IperionX during the 4th quarter worth approximately $4,249,000. Private Advisor Group LLC increased its holdings in IperionX by 69.9% during the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock valued at $1,643,000 after purchasing an additional 25,964 shares in the last quarter. Finally, Bank of America Corp DE increased its holdings in IperionX by 69.0% during the 2nd quarter. Bank of America Corp DE now owns 35,441 shares of the company’s stock valued at $1,116,000 after purchasing an additional 14,467 shares in the last quarter. Institutional investors and hedge funds own 2.76% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Roth Capital reiterated a “buy” rating on shares of IperionX in a research note on Monday, June 8th. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. BTIG Research increased their price objective on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a research note on Friday, June 5th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $60.33.

Read Our Latest Analysis on IperionX

About IperionX

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Featured Articles

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.